The Extracellular Matrix Protein 1: Its Molecular Interaction and Implication in Tumor Progression

REFERENCES

• Mathieu E., Meheus L., Raymackers J., Merregaert J. Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res 1994; 6: 903–913
   Google Scholar
• Bhalerao J., Tylzanowski P., Filie J. D., Kozak C. A., Merregaert J. Molecular cloning, characterization, and genetic mapping of the cDNA coding for a novel secretory protein of mouse. Demonstration of alternative splicing in skin and cartilage. J Biol Chem 1995; 27: 16385–16394
   Google Scholar
• Smits P., Ni J., Feng P., Wauters J., Van Hul W., Boutaibi M. E., Dillon P. J., Merregaert J. The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics 1997; 3(45)487–495
   Google Scholar
• Johnson M. R., Wilkin D. J., Vos H. L., Ortiz de Luna R. I., Dehejia A. M., Polymeropoulos M. H., Francomano C. A. Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21. Matrix Biol 1997; 5(16)289–292
   Google Scholar
• Smits P., Poumay Y., Karperien M., Tylzanowski P., Wauters J., Huylebroeck D., Ponec M., Merregaert J. Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J Invest Dermatol 2000; 4(114)718–724
   Google Scholar
• Sander C. S., Sercu S., Ziemer M., Hipler U. C., Elsner P., Thiele J. J., Merregaert J. Expression of extracellular matrix protein 1 (ECM1) in human skin is decreased by age and increased upon ultraviolet exposure. Br J Dermatol 2006; 2(154)218–224
   Google Scholar
• Mongiat M., Fu J., Oldershaw R., Greenhalgh R., Gown A. M., Iozzo R. V. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem 2003; 19(278)17491–17499
   Google Scholar
• Horev L., Potikha T., Ayalon S., Molho-Pessach V., Ingber A., Gany M. A., Edin B. S., Glaser B., Zlotogorski A. A novel splice-site mutation in ECM-1 gene in a consanguineous family with lipoid proteinosis. Exp Dermatol 2005; 12(14)891–897
   Google Scholar
• Han Z., Ni J., Smits P., Underhill C. B., Xie B., Chen Y., Liu N., Tylzanowski P., Parmelee D., Feng P., Ding I., Gao F., Gentz R., Huylebroeck D., Merregaert J., Zhang L. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J 2001; 6(15)988–994
   Google Scholar
• Deckers M. M., Smits P., Karperien M., Ni J., Tylzanowski P., Feng P., Parmelee D., Zhang J., Bouffard E., Gentz R., Lowik C. W., Merregaert J. Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone 2001; 1(28)14–20
   Google Scholar
• Wang L., Yu J., Ni J., Xu X. M., Wang J., Ning H., Pei X. F., Chen J., Yang S., Underhill C. B., Liu L., Liekens J., Merregaert J., Zhang L. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 2003; 1(200)57–67
   Google Scholar
• Hamada T. Lipoid proteinosis. Clin Exp Dermatol 2002; 8(27)624–629
   Google Scholar
• Chan I. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 2004; 1(29)52–56
   Google Scholar
• Hamada T., McLean W. H., Ramsay M., Ashton G. H., Nanda A., Jenkins T., Edelstein I., South A. P., Bleck O., Wessagowit V., Mallipeddi R., Orchard G. E., Wan H., Dopping-Hepenstal P. J., Mellerio J. E., Whittock N. V., Munro C. S., van Steensel M. A., Steijlen P. M., Ni J., Zhang L., Hashimoto T., Eady R. A., McGrath J. A. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet 2002; 7(11)833–840
   Google Scholar
• Fujimoto N., Terlizzi J., Brittingham R., Fertala A., McGrath J. A., Uitto J. Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2. Biochem Biophys Res Commun 2005; 4(333)1327–1333
   Google Scholar
• Fujimoto N., Terlizzi J., Aho S., Brittingham R., Fertala A., Oyama N., McGrath J. A., Uitto J. Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions. Exp Dermatol 2006; 4(15)300–307
   Google Scholar
• Dunlevy J. R., Beales M. P., Berryhill B. L., Cornuet P. K., Hassell J. R. Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. Exp Eye Res 2000; 3(70)349–362
   Google Scholar
• Hamada T., Wessagowit V., South A. P., Ashton G. H., Chan I., Oyama N., Siriwattana A., Jewhasuchin P., Charuwichitratana S., Thappa D. M., Jeevankumar B., Lenane P., Krafchik B., Kulthanan K., Shimizu H., Kaya T. I., Erdal M. E., Paradisi M., Paller A. S., Seishima M., Hashimoto T., McGrath J. A. Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol 2003; 3(120)345–350
   Google Scholar
• Murdoch A. D., Liu B., Schwarting R., Tuan R. S., Iozzo R. V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 1994; 2(42)239–249
   Google Scholar
• Handler M., Yurchenco P. D., Iozzo R. V. Developmental expression of perlecan during murine embryogenesis. Dev Dyn 1997; 2(210)130–145
   Google Scholar
• Mongiat M., Sweeney S. M., San Antonio J. D., Fu J., Iozzo R. V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003; 6(278)4238–4249
   Google Scholar
• Park J. E., Keller G. A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 12(4)1317–1326
   Google Scholar
• Maeshima Y., Colorado P. C., Torre A., Holthaus K. A., Grunkemeyer J. A., Ericksen M. B., Hopfer H., Xiao Y., Stillman I. E., Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 2000; 28(275)21340–21348
   Google Scholar
• Dhanabal M., LaRochelle W. J., Jeffers M., Herrmann J., Rastelli L., McDonald W. F., Chillakuru R. A., Yang M., Boldog F. L., Padigaru M., McQueeney K. D., Wu F., Minskoff S. A., Shimkets R. A., Lichenstein H. S. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res 2002; 13(62)3834–3841
   Google Scholar
• Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992; 16(267)10931–10934
   Google Scholar
• Brooks P. C., Montgomery A. M., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 7(79)1157–1164
   Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1(1)27–31
   PubMed Web of Science ®Google Scholar
• Argraves W. S., Greene L. M., Cooley M. A., Gallagher W. M. Fibulins: physiological and disease perspectives. EMBO Rep 2003; 12(4)1127–1131
   Google Scholar
• Timpl R., Sasaki T., Kostka G., Chu M. L. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003; 6(4)479–489
   Google Scholar
• Qing J., Maher V. M., Tran H., Argraves W. S., Dunstan R. W., McCormick J. J. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 1997; 18(15)2159–2168
   Google Scholar
• Ravanti L., Kahari V. M. Matrix metalloproteinases in wound repair (review). Int J Mol Med 2000; 4(6)391–407
   Google Scholar
• Hangai M., Kitaya N., Xu J., Chan C. K., Kim J. J., Werb Z., Ryan S. J., Brooks P. C. Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol 2002; 4(161)1429–1437
   Google Scholar
• Xu J., Rodriguez D., Petitclerc E., Kim J. J., Hangai M., Moon Y. S., Davis G. E., Brooks P. C. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001; 5(154)1069–1079
   Google Scholar
• Hamano Y., Zeisberg M., Sugimoto H., Lively J. C., Maeshima Y., Yang C., Hynes R. O., Werb Z., Sudhakar A., Kalluri R. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003; 6(3)589–601
   Google Scholar
• Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 2(14)163–176
   Google Scholar
• Olsen D. R., Chu M. L., Uitto J. Expression of basement membrane zone genes coding for type IV procollagen and laminin by human skin fibroblasts in vitro: elevated alpha 1 (IV) collagen mRNA levels in lipoid proteinosis. J Invest Dermatol 1988; 5(90)734–738
   Google Scholar
• Bergers G., Brekken R., McMahon G., Vu T. H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 10(2)737–744
   Google Scholar
• Belotti D., Paganoni P., Manenti L., Garofalo A., Marchini S., Taraboletti G., Giavazzi R. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 2003; 17(63)5224–5229
   Google Scholar
• Blouw B., Song H., Tihan T., Bosze J., Ferrara N., Gerber H. P., Johnson R. S., Bergers G. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003; 2(4)133–146
   Google Scholar
• Rahman M. A., Toi M. Anti-angiogenic therapy in breast cancer. Biomedicine & Pharmacotherapy 2003, 57: 463–470
   PubMedGoogle Scholar
• Han Z., Ni J., Smits P., Underhill C. B., Xie B., Chen Y., Liu N., Tylzanowski P., Parmelee D., Feng P., Ding I., Gao F., Gentz R., Huylebroeck D., Merregaert J., Zhang L. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J 2001; 6(15)988–994
   Google Scholar
• Thomas K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 2(271)603–606
   Google Scholar
• Nguyen M. Angiogenic factors as tumor markers. Invest New Drugs 1997; 1(15)29–37
   Google Scholar
• Bachelder R. E., Crago A., Chung J., Wendt M. A., Shaw L. M., Robinson G., Mercurio A. M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 15(61)5736–5740
   Google Scholar
• Chung J., Bachelder R. E., Lipscomb E. A., Shaw L. M., Mercurio A. M. Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 2002; 1(158)165–174
   Google Scholar
• Bates D. O., Harper S. J. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002; 4–5(39)225–237
   Google Scholar
• Han Z., Lin G., Huang J., Chi F., Zhang L. The relationship between ECM1 and the angiogenesis and metastasis of laryngeal carcinoma. Lin. Chuang. Er. Bi Yan. Hou Ke. Za Zhi. 2006; 3(20)116–8; 121
   Google Scholar
• Pauws E., Veenboer G. J., Smit J. W., de Vijlder J. J., Morreau H., Ris-Stalpers C. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles. FASEB J 2004; 3(18)560–561
   Google Scholar
• van de Velde C. J. H., van Krieken J. H. J. M., de Mulder P. H. M., Vermorken J. B. Oncologie. Bohn Stafleu van Loghum 2005
   Google Scholar
• Su H., Hu N., Shih J., Hu Y., Wang Q. H., Chuang E. Y., Roth M. J., Wang C., Goldstein A. M., Ding T., Dawsey S. M., Giffen C., Emmert-Buck M. R., Taylor P. R. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003; 14(63)3872–3876
   Google Scholar
• Hu N., Qian L., Hu Y., Shou J. Z., Wang C., Giffen C., Wang Q. H., Wang Y., Goldstein A. M., Emmert-Buck M. R., Taylor P. R. Quantitative real-time RT-PCR validation of differential mRNA expression of SPARC FADD Fascin COL7A1 CK4 TGM3 ECM1 PPL EVPL in esophageal squamous cell carcinoma. BMC Cancer 2006, 6
   Google Scholar
• Schlumberger M. J. Papillary and follicular thyroid carcinoma. N Engl. J Med 1998; 5(338)297–306
   Google Scholar
• Krohn K., Paschke R. Somatic mutations in thyroid nodular disease. Mol Genet Metab 2002; 3(75)202–208
   Google Scholar
• Tuttle R. M., Lemar H., Burch H. B. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998; 5(8)377–383
   Google Scholar
• Basu D., Jayaram G. A logistic model for thyroid lesions. Diagn Cytopathol 1992; 1(8)23–27
   Google Scholar
• Tyler D. S., Winchester D. J., Caraway N. P., Hickey R. C., Evans D. B. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 1994; 6(116)1054–1060
   Google Scholar
• Eldar S., Sabo E., Cohen A., Misselevich I., Abrahamson J., Cohen O., Kelner J., Boss J. H. The value of histomorphometric nuclear parameters in the diagnosis of well differentiated follicular carcinomas and follicular adenomas of the thyroid gland. Histopathology 1999; 5(34)453–461
   Google Scholar
• Mazzaferri E. L., Robbins R. J., Spencer C. A., Braverman L. E., Pacini F., Wartofsky L., Haugen B. R., Sherman S. I., Cooper D. S., Braunstein G. D., Lee S., Davies T. F., Arafah B. M., Ladenson P. W., Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 4(88)1433–1441
   Google Scholar
• Dean D. S., Hay I. D. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000; 3(7)229–239
   Google Scholar
• Greaves T. S., Olvera M., Florentine B. D., Raza A. S., Cobb C. J., Tsao-Wei D. D., Groshen S., Singer P., Lopresti J., Martin S. E. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 2000; 6(90)335–341
   Google Scholar
• Baloch Z. W., Fleisher S., LiVolsi V. A., Gupta P. K. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002; 1(26)41–44
   Google Scholar
• Hooft L., Hoekstra O. S., Boers M., Van Tulder M. W., Van D. P., Lips P. Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital. Thyroid 2004; 4(14)287–293
   Google Scholar
• Kebebew E., Peng M., Reiff E., McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 2006; 12(106)2592–2597
   Google Scholar
• Kebebew E., Peng M., Reiff E., Duh Q. Y., Clark O. H., McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 2005; 3(242)353–361
   Google Scholar
• Netzel-Arnett S., Hooper J. D., Szabo R., Madison E. L., Quigley J. P., Bugge T. H., Antalis T. M. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 2003; 2–3(22)237–258
   Google Scholar
• Wallrapp C., Hahnel S., Muller-Pillasch F., Burghardt B., Iwamura T., Ruthenburger M., Lerch M. M., Adler G., Gress T. M. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 2000; 10(60)2602–2606
   Google Scholar
• Kebebew E., Hwang J., Reiff E., Duh Q. Y., Clark O. H. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 2006; 8(141)777–782
   Google Scholar
• Kebebew E., Peng M., Reiff E., Duh Q. Y., Clark O. H., McMillan A. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World J Surg 2006; 5(30)767–774
   Google Scholar
• Katoh R., Miyagi E., Kawaoi A., Hemmi A., Komiyama A., Oyama T., Shibuya M. Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms. Hum Pathol 1999; 8(30)891–897
   Google Scholar
• Klein M., Vignaud J. M., Hennequin V., Toussaint B., Bresler L., Plenat F., Leclere J., Duprez A., Weryha G. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab 2001; 2(86)656–658
   Google Scholar
• Lennard C. M., Patel A., Wilson J., Reinhardt B., Tuman C., Fenton C., Blair E., Francis G. L., Tuttle R. M. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 2001; 5(129)552–558
   Google Scholar
• Akslen L. A., LiVolsi V. A. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum Pathol 2000; 4(31)439–442
   Google Scholar
• Bissell M. J., Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1(1)46–54
   PubMed Web of Science ®Google Scholar
• Liotta L. A., Kohn E. C. The microenvironment of the tumour-host interface. Nature 2001; 6835(411)375–379
   Web of Science ®Google Scholar
• Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 6303(348)699–704
   Google Scholar
• Hewitt R., Dano K. Stromal cell expression of components of matrix-degrading protease systems in human cancer. Enzyme Protein 1996; 1–3(49)163–173
   Google Scholar
• Hasan J., Byers R., Jayson G. C. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002; 10(86)1566–1577
   Google Scholar
• Sasano H., Ohashi Y., Suzuki T., Nagura H. Vascularity in human adrenal cortex. Mod Pathol 1998; 4(11)329–333
   Google Scholar
• Hasan J., Byers R., Jayson G. C. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002; 10(86)1566–1577
   Google Scholar
• Hanahan D., Christofori G., Naik P., Arbeit J. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 1996; 14(32A)2386–2393
   Google Scholar
• Cadigan K. M., Nusse R. Wnt meeting 1996. Biochim Biophys Acta 1997; 1(1332)R1–R5
   Google Scholar
• Hall C. L., Kang S., MacDougald O. A., Keller E. T. Role of Wnts in prostate cancer bone metastases. J Cell Biochem 2006; 4(97)661–672
   Google Scholar
• Tsukamoto A. S., Grosschedl R., Guzman R. C., Parslow T., Varmus H. E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988; 4(55)619–625
   Google Scholar
• Kenny P. A., Enver T., Ashworth A. Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells. BMC. Cancer 2005, 5: 3
   PubMedGoogle Scholar
• Cairns R. A., Khokha R., Hill R. P. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003; 7(3)659–671
   Google Scholar
• Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 3(2)161–174
   Google Scholar
• Nabeshima K., Iwasaki H., Koga K., Hojo H., Suzumiya J., Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006; 7(56)359–367
   Google Scholar
• Li J. Y. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982, 62: 113–120
   PubMedGoogle Scholar
• Pawlak G., Helfman D. M. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001; 1(11)41–47
   Google Scholar